140 related articles for article (PubMed ID: 34738049)
41. Staging and prognosis of oropharyngeal carcinoma according to the 8th Edition of the American Joint Committee on Cancer Staging Manual in human papillomavirus infection.
Yamashita Y; Ikegami T; Hirakawa H; Uehara T; Deng Z; Agena S; Uezato J; Kondo S; Kiyuna A; Maeda H; Suzuki M; Ganaha A
Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):827-836. PubMed ID: 30594962
[TBL] [Abstract][Full Text] [Related]
42. Comparing Outcomes for Patients with Human Papillomavirus (HPV) Type 16 versus Other High-Risk HPV Types in Oropharyngeal Squamous Cell Carcinoma.
Shenker RF; May NH; Waltonen JD; Yang JP; O'Neill SS; Frizzell BA; Greven KM; Hughes RT
Head Neck Pathol; 2021 Sep; 15(3):866-874. PubMed ID: 33616854
[TBL] [Abstract][Full Text] [Related]
43. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
Horne ZD; Glaser SM; Vargo JA; Ferris RL; Balasubramani GK; Clump DA; Heron DE; Beriwal S
Cancer; 2016 Jul; 122(13):2021-30. PubMed ID: 27111669
[TBL] [Abstract][Full Text] [Related]
44. Definitive tumor directed therapy confers a survival advantage for metachronous oligometastatic HPV-associated oropharyngeal cancer following trans-oral robotic surgery.
Wright CM; Lee DY; Shimunov D; Carmona R; Barsky AR; Sun L; Cohen RB; Bauml JM; Brody RM; Basu D; Rassekh CH; Chalian AA; Newman JG; Rajasekaran K; Weinstein GS; Lukens JN; Lin A; Swisher-McClure S
Oral Oncol; 2021 Oct; 121():105509. PubMed ID: 34474270
[TBL] [Abstract][Full Text] [Related]
45. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
[TBL] [Abstract][Full Text] [Related]
46. Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.
Mes SW; van Velden FHP; Peltenburg B; Peeters CFW; Te Beest DE; van de Wiel MA; Mekke J; Mulder DC; Martens RM; Castelijns JA; Pameijer FA; de Bree R; Boellaard R; Leemans CR; Brakenhoff RH; de Graaf P
Eur Radiol; 2020 Nov; 30(11):6311-6321. PubMed ID: 32500196
[TBL] [Abstract][Full Text] [Related]
47. Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.
Mizumachi T; Homma A; Sakashita T; Kano S; Hatakeyama H; Fukuda S
Int J Clin Oncol; 2017 Aug; 22(4):682-689. PubMed ID: 28271391
[TBL] [Abstract][Full Text] [Related]
48. Prognostic impact of PD-L1 in oropharyngeal cancer after primary curative radiotherapy and relation to HPV and tobacco smoking.
Lilja-Fischer JK; Eriksen JG; Georgsen JB; Vo TT; Larsen SR; Cheng J; Busch-Sørensen M; Aurora-Garg D; Steiniche T; Overgaard J
Acta Oncol; 2020 Jun; 59(6):666-672. PubMed ID: 32079442
[No Abstract] [Full Text] [Related]
49. Poor prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinomas that overexpress hypoxia inducible factor-1α.
Swartz JE; Pothen AJ; van Kempen PM; Stegeman I; Formsma FK; Cann EM; Willems SM; Grolman W
Head Neck; 2016 Sep; 38(9):1338-46. PubMed ID: 27027530
[TBL] [Abstract][Full Text] [Related]
50. Prognosis of the 8th TNM Staging System for Penile Cancer and Refinement of Prognostication by Incorporating High Risk Human Papillomavirus Status.
Wang B; Gu W; Wan F; Wei Y; Xiao W; Lu X; Zhang G; Zhou J; Wang Q; Ding X; Azizi M; Spiess PE; Ye D; Zhu Y
J Urol; 2020 Mar; 203(3):562-569. PubMed ID: 31596650
[TBL] [Abstract][Full Text] [Related]
51. Serum lactate dehydrogenase is a predictive biomarker in patients with oropharyngeal cancer undergoing radiotherapy: Retrospective study on predictive factors.
Uehara T; Doi H; Ishikawa K; Inada M; Tatsuno S; Wada Y; Oguma Y; Kawakami H; Nakamatsu K; Hosono M; Nishimura Y
Head Neck; 2021 Oct; 43(10):3132-3141. PubMed ID: 34268826
[TBL] [Abstract][Full Text] [Related]
52. Active HPV infection and its influence on survival in head and neck squamous-cell cancer.
Janecka-Widła A; Mucha-Małecka A; Majchrzyk K; Halaszka K; Przewoźnik M; Słonina D; Biesaga B
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1677-1692. PubMed ID: 32372145
[TBL] [Abstract][Full Text] [Related]
53. A clinical prognostic model compared to the newly adopted UICC staging in an independent validation cohort of P16 negative/positive head and neck cancer patients.
Rasmussen JH; Håkansson K; Rasmussen GB; Vogelius IR; Friborg J; Fischer BM; Bentzen SM; Specht L
Oral Oncol; 2018 Jun; 81():52-60. PubMed ID: 29884414
[TBL] [Abstract][Full Text] [Related]
54. E1 detection as prognosticator in human papillomavirus-positive head and neck cancers.
Vivenza D; Lo Nigro C; Denaro N; Fortunato M; Monteverde M; Tonissi F; Lattanzio L; Astesana V; Gloghini A; Volpi CC; Russi E; Merlano MC
Int J Biol Markers; 2016; 31(2):0. PubMed ID: 27040135
[TBL] [Abstract][Full Text] [Related]
55. HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer.
Klozar J; Kratochvil V; Salakova M; Smahelova J; Vesela E; Hamsikova E; Betka J; Tachezy R
Eur Arch Otorhinolaryngol; 2008 Jul; 265 Suppl 1():S75-82. PubMed ID: 18094985
[TBL] [Abstract][Full Text] [Related]
56. [HPV-related oropharyngeal squamous cell carcinoma-Incidence steadily rising].
Suchan M; Wuerdemann N; Sharma SJ; Klussmann JP
HNO; 2021 Jul; 69(7):599-608. PubMed ID: 34143237
[TBL] [Abstract][Full Text] [Related]
57. p16
Brauswetter D; Birtalan E; Danos K; Kocsis A; Krenacs T; Timar J; Mihalyi R; Horcsik D; Polony G; Tamas L; Petak I
Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1959-1965. PubMed ID: 27999998
[TBL] [Abstract][Full Text] [Related]
58. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
[TBL] [Abstract][Full Text] [Related]
59. Mid-treatment Fluorodeoxyglucose Positron Emission Tomography in Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma Treated with Primary Radiotherapy: Nodal Metabolic Response Rate can Predict Treatment Outcomes.
Lin P; Min M; Lai K; Lee M; Holloway L; Xuan W; Bray V; Fowler A; Lee CS; Yong J
Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):e586-e598. PubMed ID: 34373179
[TBL] [Abstract][Full Text] [Related]
60. Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients.
Laban S; Gangkofner DS; Holzinger D; Schroeder L; Eichmüller SB; Zörnig I; Jäger D; Wichmann G; Dietz A; Broglie MA; Herold-Mende CC; Dyckhoff G; Boscolo-Rizzo P; Ezić J; Marienfeld R; Möller P; Kraus JM; Völkel G; Kestler HA; Brunner C; Schuler PJ; Wigand MC; Theodoraki MN; Doescher J; Hoffmann TK; Pawlita M; Waterboer T; Butt J
Clin Cancer Res; 2019 Dec; 25(24):7405-7412. PubMed ID: 31444248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
